Member Info for TonyFawcett

With this momentum we could break through £1 today as anticipation attracts buyers who want to be in on this. The news flow and publicity will pick up from now forcing the price towards £2 in the coming days and weeks. We have a few hurdles to jump before we see £5 but it is possible in the medium term if all works out to plan.

Roll on next Thursday

Enjoy the ride, we're just on the warm up lap, wait for the race to start, then hold on.

MM’s trying to temp some sellers , tree shaking. Buys far exceeds sells, it will be blue again soon , they won’t want to be out of this over the weekend.

We must be on the radar of some big Pharmaceutical Companies, especially at this low price , the Vulchers must be circulating .

I am assuming the placing was not a public placing but one to institutional shareholders , that’s why I also assume the placing has not been pulled as it it would tarnish Avactas reputation for future fund raising amount institutions. However we are soon to be past that and the shares will move forward.

It is highly likely we could soon be a takeover target especially with the Affirmers we have, the IP we have, the tie ups with major pharmaceuticals make us a target especially whilst the share price is still low compared to the potential income .

Both UK and Scotish Governments have confirmed that lifting of the Lockdown and social distancing is dependent on testing. Rapid testing is the preferred option because of the speed and cost associated with the test. The Government is aware of AVCT and is watching developments closely.

I don’t think even the placing investors would want to sell given the potential and expected news flow in AVCT , this is only going one way and that’s up. Short , medium and long term.

As this information is in the public domain and the SP should already be higher than it already is with the recent news. It is safe to assume that the issue of new shares will already be factored in to the current SP.
IMO
DYOR

SP is being held back probably trying to fill buy orders , can’t see many wanting to sell at this price unless they are traders or forced sellers, maybe this is who the mom’s want to flush out. I think once the states wakes up , it will make further advances on the SP as mm’s will struggle to hold this back much longer, looking at today’s trades so far and the relentless demand since this mornings news.

Comek2

I did exactly the same as you AVCT could be massive short term. I am already over 50% up .
I have kept a few Bloe shares and will get back before in the not too distant future as I still believe once the gas comes on line then it will be a game changer but with the depressed Oil industry at the moment I can’t see it going anywhere fast. However AVCT could be a multibagger in the short term.

Plus many more deals/collaborations in the Pipeline, Cytiva have not got exclusive rights . Looking forward to market open and the next few weeks in this rapidly moving market place .

The UK market seems to have dismissed the Moderna link , I would have nailed it on for a rise today. God bless America

After the last RNS I reluctantly substantially reduced my holding in BLOE, and have divested into AVCT and GGP, both are showing decent gains and potential . I will invest back into BLOE when I think the tide has turned, I still believe in BLOE but it may take longer than originally planned. Oil price is looking vulnerable again which will affect sentiment.

Not the start we expected, the euphoria doesn’t seem to have filtered through yet. Hopefully SP will rise substantially when we get some news,

Any guesses as to tomorrow’s SP and end of next week SP ?

The next couple of weeks could see a major re rate in AVCT , actually not could but will.

Let the day traders take their profit and spending money for the weekend. This afternoon the investors will move in to get a position before next weeks updates .

Yes a Vaccine would be fantastic but that is at least 18 months away , in the meantime to protect each other and to get the economy moving even at a modicum of before is what is wanted now.
For mass testing we need a rapid test, no sending off to labs for analysis that’s too expensive.
AVCT is the answer at the head of the queue right now.